Ligand Pharmaceuticals Incorporated (LGND)
Jul 2, 2025 - LGND was delisted (reason: merged into PTHS)
113.30
+0.74 (0.66%)
Inactive · Last trade price
on Jul 2, 2025
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$2,668,941
Profits / Employee
-$1,950,324
Market Cap
2.75B
Employees Chart
LGND News
- 18 hours ago - Ligand Announces Closing of Convertible Senior Notes Offering - GlobeNewsWire
- 3 days ago - Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering - GlobeNewsWire
- 4 days ago - Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030 - GlobeNewsWire
- 7 days ago - Ligand Pharmaceuticals Incorporated (LGND) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance - GlobeNewsWire
- 14 days ago - Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewsWire
- 22 days ago - Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 5 weeks ago - Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™ - GlobeNewsWire